Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-03 Sale |
2025-03-05 4:21 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,264 | $243.78 | $308,141 | 57,608 (Indirect Direct) |
View |
| 2025-02-28 Sale |
2025-03-03 4:31 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
796 | $241.7 | $192,390 | 35,863 (Indirect Direct) |
View |
| 2025-02-14 Sale |
2025-02-18 4:47 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
967 | $255.17 | $246,750 | 32,843 (Indirect Direct) |
View |
| 2024-11-26 Sale |
2024-11-27 5:21 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,682 | $250.98 | $422,144 | 30,701 (Indirect Direct) |
View |
| 2024-06-25 Sale |
2024-06-26 4:26 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,605 | $231 | $370,747 | 28,949 (Indirect Direct) |
View |
| 2024-02-28 Sale |
2024-02-29 4:18 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
574 | $155.3 | $89,145 | 23,351 (Indirect Direct) |
View |
| 2024-02-16 Sale |
2024-02-20 4:08 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,007 | $148.06 | $149,099 | 18,201 (Indirect Direct) |
View |
| 2023-08-04 Sale |
2023-08-07 6:05 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,460 | $185.85 | $643,037 | 15,930 (Indirect Direct) |
View |
| 2023-04-27 Sale |
2023-04-28 5:55 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
977 | $194.59 | $190,113 | 11,763 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Option Award |
2025-03-05 4:21 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
24,917 | $0 | 57,608 (Direct) |
View |
| 2025-02-27 Exercise |
2025-03-03 4:31 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,908 | $0 | 35,863 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:47 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,109 | $0 | 32,843 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-27 5:21 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,434 | $0 | 30,701 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 4:26 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,278 | $0 | 28,949 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-14 6:21 pm |
N/A 2034-06-14 |
CervoMed Inc. | CRVO | Poulton Jeffrey V. Director |
5,750 | $0 | 5,750 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 4:21 pm |
N/A 2034-03-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
22,859 | $0 | 42,394 (Direct) |
View |
| 2024-02-27 Exercise |
2024-02-29 4:18 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,908 | $0 | 23,351 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 4:08 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,278 | $0 | 18,201 (Direct) |
View |
| 2023-09-15 Option Award |
2023-09-15 6:52 pm |
N/A 2033-09-15 |
CervoMed Inc. | CRVO | Poulton Jeffrey V. Director |
6,450 | $0 | 6,450 (Direct) |
View |
Ownership |
2023-08-23 9:48 pm |
N/A 2028-05-29 |
CervoMed Inc. | CRVO | Poulton Jeffrey V. Director |
0 | $0 | 14,963 (Direct) |
View |
| 2023-08-03 Option Award |
2023-08-07 6:05 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
7,627 | $0 | 15,930 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 6:09 pm |
N/A 2033-06-14 |
Homology Medicines Inc. | FIXX | Poulton Jeffrey V. Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2023-04-26 Option Award |
2023-04-28 5:55 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,277 | $0 | 11,763 (Direct) |
View |
| 2023-02-27 Option Award |
2023-03-01 4:21 pm |
N/A 2026-02-27 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
17,574 | $0 | 17,574 (Direct) |
View |
| 2022-08-04 Tax Withholding |
2022-08-05 4:14 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
4,573 | $189.76 | 9,463 (Direct) |
View |
| 2022-08-04 Tax Withholding |
2022-08-05 4:14 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
146 | $209.88 | 9,463 (Direct) |
View |
| 2022-08-04 Tax Withholding |
2022-08-05 4:14 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
173 | $210.5 | 9,463 (Direct) |
View |
| 2022-08-04 Tax Withholding |
2022-08-05 4:14 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
162 | $209.83 | 9,463 (Direct) |
View |
| 2022-08-03 Option Award |
2022-08-05 4:14 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
11,325 | $0 | 9,463 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:05 pm |
N/A 2032-06-15 |
Homology Medicines Inc. | FIXX | Poulton Jeffrey V. Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-02-23 Option Award |
2022-02-25 4:12 pm |
N/A 2032-02-22 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
18,413 | $0 | 18,413 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 5:39 pm |
N/A 2031-06-17 |
Homology Medicines Inc. | FIXX | Poulton Jeffrey V. Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2021-02-24 Option Award |
2021-02-26 4:04 pm |
N/A 2031-02-23 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. Chief Financial Officer |
23,200 | $0 | 23,200 (Direct) |
View |
| 2020-07-21 Option Award |
2020-07-21 5:31 pm |
N/A 2030-07-20 |
Homology Medicines Inc. | FIXX | Poulton Jeffrey V. Director |
36,000 | $0 | 36,000 (Direct) |
View |